MBX Biosciences, Inc. Common Stock (MBX) NASDAQ

15.49

+0.53(+3.54%)

Updated at July 30 04:00PM

Currency In USD

Valuation

Market Cap615.43M
Enterprise Value566.25M
P/E Ratio-7.04
PEG Ratio0.85
Price/Sales Ratio0
Price/Book Ratio2.2
Enterprise/Revenue0
Enterprise/EBITDA-6.05

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.3
Return On Equity-0.44

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-67.95M
Net Income-61.92M
Diluted EPS-1.85

Balance Sheet

Total Cash240.79M
Total Cash/Share7.21
Total Debt130,000
Total Debt/Equity0
Current Ratio23.31
Book Value Per Share7.05

Price History

52-Week Change-34.5
52-Week High27.5
52-Week Low4.81
Moving Average 50 Days12.24
Moving Average 200 Days13.7

Statistics

Average Volume344,470
Shares Outstanding33.42M
% Held by Institutions106.75

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A